Dicerna Pharmaceuticals Inc (DRNA) Earnings History & Surprises

NASDAQ:DRNA

38.22
+0.22 (+0.58%)
At close: Dec 27, 2021
38.24
+0.02 (+0.05%)
After Hours: 12/27/2021, 8:42:47 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for Dicerna Pharmaceuticals Inc (DRNA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMar 4, 2022
PeriodQ4 / 2021
EPS Estimate-$0.55
Revenue Estimate42.092M

Last Reported

Most Recent
Release DateN/A
PeriodQ3 / 2021
EPS Reported-$0.22
EPS Surprise 53.46%
Revenue Surprise 40.97%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History ()

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2021 -0.22 -0.47 53.46% 24.14% 62.954M 44.657M 40.97% 28.79%
Q2 2021 -0.53 0.42 -226.24% -23.26% 41.337M 93.117M -55.61% 2.19%
Q1 2021 -0.39 -0.38 -3.09% -25.81% 47.6M 47.202M 0.84% 39.88%
Q4 2020 -0.49 -0.03 -1,672.01% - 40.96M 68.597M -40.29% -
Q3 2020 -0.29 -0.20 -42.56% - 48.88M 52.53M -6.95% -
Q2 2020 -0.43 0.10 -520.31% - 40.45M 63.546M -36.35% -
Q1 2020 -0.31 0.27 -214.04% - 34.03M 61.024M -44.24% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

DRNA EPS Q2Q GrowthDRNA EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 -50 -100

Revenue Historical Q2Q growth and Acceleration

DRNA Revenue Q2Q GrowthDRNA Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 20 -20 -40

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Related analysis

DRNA Overview DRNA Technical Analysis Report DRNA Fundamental Analysis Report DRNA Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

Dicerna Pharmaceuticals Inc / DRNA Earnings FAQ

Did DRNA stock beat earnings estimates in the most recent quarter?

Dicerna Pharmaceuticals Inc (DRNA) beat EPS estimates and beat revenue estimates in the most recent quarter.